| Secondary |
| Hypertension |
21.7% |
| Arrhythmia |
13.0% |
| Asthma |
8.7% |
| Blood Cholesterol |
8.7% |
| Migraine |
8.7% |
| Parkinson's Disease |
8.7% |
| Paroxysmal Nocturnal Haemoglobinuria |
8.7% |
| Arthralgia |
4.3% |
| Cardiac Disorder |
4.3% |
| Depression |
4.3% |
| Headache |
4.3% |
| Smoking Cessation Therapy |
4.3% |
|
| Asthenia |
11.8% |
| Death |
11.8% |
| Rash Generalised |
11.8% |
| Suicide Attempt |
11.8% |
| Vasculitis |
11.8% |
| Dizziness |
5.9% |
| Drug Interaction |
5.9% |
| Multiple Drug Overdose Intentional |
5.9% |
| Somnolence |
5.9% |
| Sudden Cardiac Death |
5.9% |
| Transaminases Increased |
5.9% |
| Vascular Graft |
5.9% |
|
| Concomitant |
| Cardiac Disorder |
14.4% |
| Smoking Cessation Therapy |
12.8% |
| Osteoporosis |
8.5% |
| Product Used For Unknown Indication |
6.7% |
| Type 2 Diabetes Mellitus |
6.7% |
| Diabetes Mellitus |
6.4% |
| Prostate Cancer |
6.2% |
| Drug Use For Unknown Indication |
5.6% |
| Pain |
5.6% |
| Hypertension |
3.8% |
| Nuclear Magnetic Resonance Imaging Brain |
2.8% |
| Panic Attack |
2.8% |
| Blood Cholesterol |
2.6% |
| Blood Pressure |
2.6% |
| Peritoneal Dialysis |
2.3% |
| Angiogram |
2.1% |
| Atrial Fibrillation |
2.1% |
| Blood Cholesterol Increased |
2.1% |
| Hepatic Neoplasm Malignant Non-resectable |
2.1% |
| Pneumonia |
2.1% |
|
| Nausea |
12.1% |
| Weight Decreased |
10.0% |
| Vomiting |
9.3% |
| Somnolence |
7.1% |
| Wrong Technique In Drug Usage Process |
6.4% |
| Drug Ineffective |
5.7% |
| Myocardial Infarction |
5.7% |
| Weight Increased |
5.7% |
| Dyspnoea |
4.3% |
| Haematochezia |
3.6% |
| Rash |
3.6% |
| Vision Blurred |
3.6% |
| Aspartate Aminotransferase Increased |
2.9% |
| Chest Pain |
2.9% |
| Constipation |
2.9% |
| Nephrogenic Systemic Fibrosis |
2.9% |
| Off Label Use |
2.9% |
| Pain In Extremity |
2.9% |
| Tremor |
2.9% |
| Unevaluable Event |
2.9% |
|
| Interacting |
| Cardiac Disorder |
50.0% |
| Multiple Sclerosis |
25.0% |
| Type 1 Diabetes Mellitus |
25.0% |
|
| Drug Interaction |
50.0% |
| Vision Blurred |
50.0% |
|
